期刊档案 · Biochemistry, Genetics and Molecular Biology-Biophysics

Biochemistry and Biophysics Reports

ISSN 2405-5808 · Elsevier · Netherlands

Biochemistry and Biophysics Reports 中科院 生物学 4区(2025 年升级版),影响因子 3.3(官网公布),完全开放获取,APC 约 2,750 美元,近 24 个月 108 篇文章投稿到接收中位 119 天,2025 年发文 502 篇,ESCI、Scopus 收录。

影响因子3.3期刊官网公布的最新值
中科院分区生物学 4区2025 年升级版大类 · 2026 新锐版 生物学 3区
审稿周期119 天投稿到接收中位数 · 近 24 个月 108 篇文章 · PubMed
版面费2,750 USD完全开放获取
录用比例—暂无反馈
年发文量502 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Biochemistry and Biophysics Reports 由 Elsevier 出版,属中科院生物学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 MicroRNA in disease regulation、Cancer-related molecular mechanisms research、Ferroptosis and cancer prognosis 等主题的论文,这 3 个主题约占 18.6%,主导子领域为 Molecular Biology、Cancer Research。(根据 OpenAlex 主题统计与中科院分区数据生成)

Biochemistry and Biophysics Reports (BB Reports) publishes original research from all scientific fields in all aspects of biochemistry and biophysics and related areas, such as molecular and cell biology and environmental toxicology.BB Reports welcomes a broad range of studies, from detailed mechanistic to more preliminary, descriptive, confirmatory, and small-scale studies, as long as the studies are solid, add new data and knowledge, have the potential to contribute to future research, and confirm or refute an existing hypothesis.Primary criteria for acceptance are that the work is experimentally and methodologically correct and that it meets the ethics and standards of experimental science.We strongly believe all results deserve to be published and documented for the advancement of science. BB Reports appreciates receiving reports on• Negative results • Replication studies • Reanalysis of previous datasetsBB Reports does accept methodological studies, but does not accept purely theoretical, hypothesis-generating studies without any experimental support and will not consider clinical/(genetic) epidemiological association studies.Reasons to submit your next article to BB Reports:Accessibility - Open access provides immediate and free online access to articles by anyone, anywhere in the world. No subscription needed.Quality - Our renowned international board of subject-specific Editors, guarantee a rigorous, fair and efficient peer review process.Speed - Articles are published online, quickly after acceptance. Articles are published constantly so there are no print delays or long waits for the next issue to be published.Discoverability - BB Reports is indexed in the Web of Science Emerging Sources Citation Index (not SCI), Scopus, PubMed Central (PMC) and the Directory of Open Access Journals (DOAJ).No Restrictions - Open access articles are online only so there are no restrictions on article length, and no additional page or color charges like many print/subscription journals. Similarly, as there are no printing costs, the environmental impact is lower.Readership - No subscriptions and no paywalls means more people can read and access an open access article, increasing author readership and usage.Author Impact - Creative commons licenses allow authors to retain copyright to their work while permitting others to share and reuse their research, increasing author impact and citations.Advancing Science - by providing access to vital research through open access, researchers across the world, including those in developing countries, can help make breakthrough discoveries which may benefit society and humanity.Option of co-submitting a data article to Data-in-Brief.View our Guide for Authors for more information, or contact us via: BBREP[at]elsevier.com.

摘自期刊官网 Aims & Scope

研究方向(LetPub):Biochemistry, Genetics and Molecular Biology-Biophysics

主编 Hans van Leeuwen出版商官网

编委会国家分布:中国大陆 2 位(约 5%);主要国家 美国 13、印度 7、荷兰 6、中国 2、英国 2(共 42 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology6.8%
  2. Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology6%
  3. Ferroptosis and cancer prognosisMedicine5.8%
  4. RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5%
  5. RNA Research and SplicingBiochemistry, Genetics and Molecular Biology4.7%
  6. Adipose Tissue and MetabolismMedicine4.5%
  7. Monoclonal and Polyclonal Antibodies ResearchMedicine4.2%
  8. Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.1%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)生物学 4 区
类别学科分区
大类生物学4 区
小类生化与分子生物学BIOCHEMISTRY & MOLECULAR BIOLOGY4 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)生物学 3 区
类别学科分区
大类生物学3 区
小类生化与分子生物学BIOCHEMISTRY & MOLECULAR BIOLOGY4 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

Web of SciencePMC出版商官网

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布)
3.3出版商官网 ·
CiteScore 2026-06
3.6LetPub ·
CiteScore(出版商公布)
3.6出版商官网 ·
SJR 2026-06
0.78LetPub ·
SNIP 2026-06
0.76LetPub ·
h-index
59OpenAlex ·
i10-index
780OpenAlex ·
两年平均被引
1.83OpenAlex ·
自引率
0%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年文章数
496LetPub ·

逐年发文量 OpenAlex 统计 · 累计 2,780 篇 · 当年数据不完整

年份发文量其中 OA被引
202639039068
2025502502831
20242652651,223
20232032031,720
20222172171,900
20213033034,683

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

119 天投稿到接收中位数 · P25–P75 74 天 – 190 天

接收到上线
中位数 6 天(108 篇)
投稿到上线
中位数 134 天
样本
108 篇有投稿与接收日期的文章(窗口内共 961 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
8 WeeksLetPub ·
投稿到首次决定
6 天出版商官网 ·
外审后首次决定
51 天出版商官网 ·
投稿到接收
106 天出版商官网 ·
接收到发表
6 天出版商官网 ·
投稿到发表(期刊自报)
约 16 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJUSD 2,750有CC BY、CC BY-NC、CC BY-NC-ND
OpenAlexUSD 2,700 / EUR 2,530 / GBP 2,160 / JPY 334,880——
LetPubUSD 2,210有—
出版商官网USD 2,830——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点6 项,摘自作者指南
摘要
≤ 250 词
关键词
1–7 个
正文篇幅
≤ 4,600 词
Highlights(研究亮点)
必须提供
图文摘要
可选
不接收
clinical/(genetic) epidemiological association studies
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型8 种
  1. hypothesisBiochemistry and Biophysics Reports does accept methodological studies, but does not accept purely theoretical, hypothesis-generating studies without any experi…未说明篇幅
  2. letters to the editorBiochemistry and Biophysics Reports does accept methodological studies, but does not accept purely theoretical, hypothesis-generating studies without any experi…未说明篇幅
  3. methods paperBiochemistry and Biophysics Reports does accept methodological studies, but does not accept purely theoretical, hypothesis-generating studies without any experi…未说明篇幅
  4. methods papersMethods papers will be considered only if they are of general importance, with considerable original and useful information. Minor improvements to existing meth…未说明篇幅
  5. reviewBiochemistry and Biophysics Reports does accept methodological studies, but does not accept purely theoretical, hypothesis-generating studies without any experi…未说明篇幅
  6. reviews and mini-reviewsReviews and mini-reviews are considered by the journal. They should be thorough and sufficiently critical and accommodate different points of view.未说明篇幅
  7. short communicationBiochemistry and Biophysics Reports does accept methodological studies, but does not accept purely theoretical, hypothesis-generating studies without any experi…未说明篇幅
  8. short communicationsShort communications report on timely results in a concise manner and require rapid dissemination. They should be no more than 4,600 words long and include no m…未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
AI 使用 Declaration of generative AI use

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

原文 ↗出版商官网 ·
作者资格 Group authorship

团体署名必须在投稿时于标题页声明,提交作者应在提交系统的“Collaborative Author Groups”下注明该团体。 模型中文摘要

Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…

原文 ↗出版商官网 ·
利益冲突 Declaration of competing interests

所有作者必须披露可能不当影响或偏袒其工作的任何财务和个人关系,并始终完成声明工具。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

原文 ↗出版商官网 ·
许可与版权 License options

作者将获得开放获取用户许可选项,建议在选择许可选项前审查这些选项及任何资助机构的许可要求。 模型中文摘要

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

原文 ↗出版商官网 ·
开放获取 Open access

该期刊建议作者访问其开放获取信息页面,以了解该期刊的开放获取选项。 模型中文摘要

We refer you to our open access information page to learn about open access options for this journal.

原文 ↗出版商官网 ·
同行评审 Peer review

该期刊采用单盲同行评审流程,投稿通常至少由一名审稿人进行独立专家评估,最终决定由编辑作出。 模型中文摘要

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of one reviewer for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Rea…

原文 ↗出版商官网 ·
预印本 Preprints

作者可按照Elsevier的文章共享政策分享预印本,分享预印本不计作先前发表,该期刊还提供免费的SSRN预印本发布服务。 模型中文摘要

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Elsevier
出版国家或地区
Netherlands
出版语言
English
ISSN
2405-5808
官方链接

常见问题

关于 Biochemistry and Biophysics Reports 的常见问题

Biochemistry and Biophysics Reports 是中科院几区期刊?

2025 年升级版分区表中,Biochemistry and Biophysics Reports 为生物学 4区,小类 生化与分子生物学 4 区。2026 年新锐版分区表中为生物学 3区。不同版本与大小类分区不能混用。

Biochemistry and Biophysics Reports 的影响因子是多少?

期刊官网公布的影响因子为 3.3,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 3.6,h-index 为 59。

Biochemistry and Biophysics Reports 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)108 篇已发表文章登记的日期,投稿到接收的中位数为 119 天(四分位 74–190 天);投稿社区反馈的平均审稿速度为约 8 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Biochemistry and Biophysics Reports 的投稿格式要求是什么?

据期刊作者指南:摘要:≤ 250 词;关键词:1–7 个;正文篇幅:≤ 4,600 词;Highlights:必须提供;图文摘要:可选。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Biochemistry and Biophysics Reports 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 42 位编委中,中国大陆 2 位(约 5%);人数最多的国家是 美国(13 位)、印度(7 位)、荷兰(6 位)。统计按编委会页面列出的机构国家计,仅供参考。

Biochemistry and Biophysics Reports 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Biochemistry and Biophysics Reports 被 ESCI、Scopus、DOAJ 收录。期刊官网自述还被 Web of Science、PMC 收录,该清单未与各数据库逐一核对。

Biochemistry and Biophysics Reports 是开放获取期刊吗?版面费多少?

Biochemistry and Biophysics Reports 为完全开放获取。APC 约 2,750 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。